Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial-Reference-Cited by-同舟云学术

Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial

Published:2006-01 Issue:1 Volume:7 Page:43-51
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Di Stasi Savino M,Giannantoni Antonella,Giurioli Arcangelo,Valenti Marco,Zampa Germano,Storti Luigi,Attisani Francesco,De Carolis Andrea,Capelli Giovanni,Vespasiani Giuseppe,Stephen Robert L

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis);Smith;J Urol,1999

2. Intravesical bacillus Calmette-Guèrin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002

3. Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial;Au;J Natl Cancer Inst,2001

4. Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C treatment for superficial bladder cancer;Wientjes;Cancer Chemother Pharmacol,1993

5. Electromotive delivery of mitomycinc C into human bladder wall;Di Stasi;Cancer Res,1997

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential benefits of concomitant statins treatment in patients with non‐muscle‐invasive bladder cancer;BJU International;2024-09-10

2. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

3. The effect of intravesical chemohyperthermia with mitomycin in non-muscle-invasive bladder tumour patients who cannot tolerate BCG treatment or recur after treatment and refuse cystectomy;International Urology and Nephrology;2024-07-31

4. BCG and bladder cancer. Forty-eight years after Morales report;Urologia Journal;2024-05-17

5. Evaluating a combination treatment of NK cells and reovirus against bladder cancer cells using an in vitro assay to simulate intravesical therapy;Scientific Reports;2024-03-28